An update on functional neuroimaging of parkinsonism and dystonia

被引:32
作者
van Eimeren, Thilo
Siebner, Hartwig Roman
机构
[1] Univ Kiel, Neurol Klin, Dept Neurol, NeuroImage N, D-24105 Kiel, Germany
[2] Univ Hamburg, Med Ctr Eppendorf, Dept Neurol, NeuroImage N, Hamburg, Germany
关键词
dystonia; functional neuroimaging; neurogenetics; Parkinson's disease; therapy;
D O I
10.1097/01.wco.0000236623.68625.54
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review The aim of this article is to review current advances-in functional magnetic resonance imaging and positron emission tomography of the motor system in parkinsonism and dystonia. Recent findings In Parkinson's disease, recent functional magnetic resonance imaging studies have shown that the pattern of regional activity changes in the motor system are strongly modulated by the amount of attention patients pay to task performance. In focal hand dystonia, functional magnetic resonance imaging has' disclosed several functional alterations in the basal ganglia in,addition to the well-known cortical abnormalities. Neuroimaging has also been successfully used to-assess the impact of pharmacological or surgical interventions. In patients with monogenetically inherited parkinsonism or dystonia, positron emission tomography and functional Magnetic resonance imaging have opened up exciting possibilities to link molecular biology with functional changes at a systems level. Neuroimaging of genetically defined at-risk populations has shown great potential to study motor reorganization at the preclinical stage and to identify adaptive mechanisms that, prevent or delay clinical manifestation. Summary Functional neuroimaging plays a key role in understanding the pathophysiology of parkinsonism and dystonia. A future challenge will be to clarify how these disorders impair the functional integration within the motor system and how. these changes in connectivity are influenced by therapeutic, interventions.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 74 条
[1]   Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine relaease [J].
Abosch, A ;
Kapur, S ;
Lang, AE ;
Hussey, D ;
Sime, E ;
Miyasaki, J ;
Houle, S ;
Lozano, AM .
NEUROSURGERY, 2003, 53 (05) :1095-1102
[2]   PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation [J].
Adams, JR ;
van Netten, H ;
Schulzer, M ;
Mak, E ;
Mckenzie, J ;
Strongosky, A ;
Sossi, V ;
Ruth, TJ ;
Lee, CS ;
Farrer, M ;
Gasser, T ;
Uitti, RJ ;
Calne, DB ;
Wszolek, ZK ;
Stoessl, AJ .
BRAIN, 2005, 128 :2777-2785
[3]   The metabolic pathology of dopa-responsive dystonia [J].
Asanuma, K ;
Ma, YL ;
Huang, CR ;
Carbon-Correll, M ;
Edwards, C ;
Raymond, D ;
Bressman, SB ;
Moeller, JR ;
Eidelberg, D .
ANNALS OF NEUROLOGY, 2005, 57 (04) :596-600
[4]   Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation [J].
Asanuma, K ;
Ma, Y ;
Okulski, J ;
Dhawan, V ;
Chaly, T ;
Carbon, M ;
Bressman, SB ;
Eidelberg, D .
NEUROLOGY, 2005, 64 (02) :347-349
[5]   Deep brain stimulation for Parkinson's disease [J].
Benabid, AL .
CURRENT OPINION IN NEUROBIOLOGY, 2003, 13 (06) :696-706
[6]  
Binkofski F, 2005, NEUROLOGY, V64, pA149
[7]   Basal ganglia activity remains elevated after movement in focal hand dystonia [J].
Blood, AJ ;
Flaherty, AW ;
Choi, JK ;
Hochberg, FH ;
Greve, DN ;
Bonmassar, G ;
Rosen, BR ;
Jenkins, BG .
ANNALS OF NEUROLOGY, 2004, 55 (05) :744-748
[8]   DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
QUINN, N ;
LEES, AJ ;
MATHIAS, CJ ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (04) :547-555
[9]   Motor reorganization in asymptomatic carriers of a single mutant Parkin allele:: a human model for presymptomatic parkinsonism [J].
Buhmann, C ;
Binkofski, F ;
Klein, C ;
Büchel, C ;
van Eimeren, T ;
Erdmann, C ;
Hedrich, K ;
Kasten, M ;
Hagenah, J ;
Deuschl, G ;
Pramstaller, PP ;
Siebner, HR .
BRAIN, 2005, 128 :2281-2290
[10]   Pharmacologically modulated fMRI -: cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients [J].
Buhmann, C ;
Glauche, V ;
Stürenburg, HJ ;
Oechsner, M ;
Weiller, C ;
Büchel, C .
BRAIN, 2003, 126 :451-461